Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial

TLR-9 agonists are immunostimulating agents that have antitumor effects in animal models. A phase I trial was conducted to define the safety profile of subcutaneous injections, combined with intrathecally administration of CpG-28, a TRL 9 agonist, in patients with neoplastic meningitis (NM). Cohorts...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Ursu, Renata, Taillibert, Sophie, Banissi, Claire, Vicaut, Eric, Bailon, Olivier, Le Rhun, Emilie, Guillamo, Jean-Sebastien, Psimaras, Dimitri, Tibi, Annick, Sacko, Adama, Marantidou, Athina, Belin, Catherine, Carpentier, Antoine F
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582991/
https://ncbi.nlm.nih.gov/pubmed/26094710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12724
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados